synced 7 MIN AGO
01 Record

CVE-2017-17678

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

UnratedPUBLISHEDCNA: mitre
CNA base scoreUnratedNo CNA CVSS vector

02 Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

03 Exploitation and scoring

Exploitation
Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.
SSVC decision
Not assessed by CISA
EPSS probability
0.59% probability of exploitation activity in the next 30 days.
EPSS percentile
Equal to or higher than the score of 48.0% of scored records. A rank, not a probability.
NVD base score
6.1 (CVSS v3.x), scored by the NVD independently of the CNA.
NVD CVSS vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
NVD analysis status
Modified. NVD last modified this record on 2026-07-09.
Red Hat severity
No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

04 Metadata

Published
2021-05-19 13:11Z5 YR AGO
Last updated
2026-07-09 00:09Z3 MO AGO
Reserved
2017-12-13
Assigning CNA
mitre
Record state
PUBLISHED
Severity
Not rated by the issuing CNA
CNA CVSS vector
Not published by the issuing CNA
Weaknesses
  • CWE-79Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')Base
Data version
5.2
Document digest
c3eae1eec0341d32ac826bcc47f29592a226f7aaf7a5e2ddc2f4d24e474ab637

05 Affected products

VendorProductVersionsPlatforms
bmcremedy_mid-tierNot specified—

06 References